Industry News
Cancer Survivors To Rise By A Third Over The Next Decade
Jun 15, 2012
The American Cancer Society has released their latest addition to its facts and figures publication called "Cancer Treatment and Survivorship Facts & Figures"... Read More
New Skin Cancer Drug Hailed As 'Greatest Advance Yet' By New England Journal Of Medicine
Jun 15, 2012
Vismodegib, a new skin cancer drug for patients with advanced basal cell carcinoma tested by TGen, Virginia G. Piper Cancer Center at Scottsdale Healthcare and Mayo Clinic, is hailed as "the greatest advance in therapy yet seen" for advanced basal cell carcinoma in an editorial in the New England Journal of Medicine... Read More
New Skin Cancer Drug Hailed As 'Greatest Advance Yet' By New England Journal Of Medicine
Jun 15, 2012
Vismodegib, a new skin cancer drug for patients with advanced basal cell carcinoma tested by TGen, Virginia G. Piper Cancer Center at Scottsdale Healthcare and Mayo Clinic, is hailed as "the greatest advance in therapy yet seen" for advanced basal cell carcinoma in an editorial in the New England Journal of Medicine... Read More
Lab-On-Chip Device Could Sort Cancer Cells
Jun 15, 2012
In life, we sort soiled laundry from clean; ripe fruit from rotten. Two Johns Hopkins engineers say they have found an easy way to use gravity or simple forces to similarly sort microscopic particles and bits of biological matter - including circulating tumor cells... Read More
Cancer Survivors To Rise By A Third Over The Next Decade
Jun 14, 2012
The American Cancer Society has released their latest addition to its facts and figures publication called "Cancer Treatment and Survivorship Facts & Figures"... Read More
Cervical Cancer Cellular Origin Discovered, Major Breakthrough
Jun 14, 2012
Researchers have identified a set of cells in the cervix that are responsible for human papillomaviruses (HPV) related cervical cancers, according to a study published in the Proceedings of the National Academy of Sciences (PNAS)... Read More
In Chronic Leukemia, Marker Distinguishes More-Aggressive From Less-Aggressive Forms
Jun 14, 2012
Researchers have identified a prognostic marker in the most common form of chronic leukemia that can help to distinguish which patients should start treatment quickly from those who can safely delay treatment, perhaps for years. The study, led by researchers at the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J... Read More
In Chronic Leukemia, Marker Distinguishes More-Aggressive From Less-Aggressive Forms
Jun 14, 2012
Researchers have identified a prognostic marker in the most common form of chronic leukemia that can help to distinguish which patients should start treatment quickly from those who can safely delay treatment, perhaps for years. The study, led by researchers at the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J... Read More
Mutant Gut Bacteria Reverse Colon Cancer In Lab Models, UF Researchers Find
Jun 14, 2012
A mutant form of a meek microbe deals a gutsy blow to colon cancer, University of Florida scientists have discovered. The special bacteria halted abnormal inflammation, reduced precancerous growths and reversed progression of severe cancerous lesions in the large intestines of mice. The findings appear June 11 in the Proceedings of the National Academy of Sciences... Read More
Promising Tool To Combat Cachexia-Induced Muscle Wasting Discovered
Jun 14, 2012
Cachexia, a syndrome characterized by rapid weight loss and muscle deterioration, is a major cause of death among patients suffering from diseases like cancer, AIDS and chronic infection. In fact, 30 per cent of cancer-related deaths are the result of cachexia-induced muscle loss rather than the primary malignancy... Read More
Previous Page Next Page